AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,545,000 | -37.5% | 150,000 | 0.0% | 0.36% | -33.1% |
| Q2 2023 | $2,472,000 | +59.4% | 150,000 | -11.8% | 0.54% | +51.7% |
| Q1 2023 | $1,551,250 | +30.4% | 170,000 | 0.0% | 0.36% | +28.5% |
| Q4 2022 | $1,190,000 | +49.7% | 170,000 | +9.0% | 0.28% | +57.4% |
| Q3 2022 | $795,000 | +108.7% | 156,000 | 0.0% | 0.18% | +114.6% |
| Q2 2022 | $381,000 | -61.5% | 156,000 | +7.6% | 0.08% | -57.9% |
| Q1 2022 | $990,000 | -15.5% | 145,000 | 0.0% | 0.20% | -8.9% |
| Q4 2021 | $1,172,000 | -17.5% | 145,000 | 0.0% | 0.21% | -22.7% |
| Q3 2021 | $1,421,000 | +61.3% | 145,000 | +11.5% | 0.28% | +54.7% |
| Q2 2021 | $881,000 | -25.0% | 130,000 | 0.0% | 0.18% | -28.4% |
| Q1 2021 | $1,175,000 | +73.0% | 130,000 | +30.0% | 0.25% | +62.3% |
| Q4 2020 | $679,000 | +124.8% | 100,000 | +66.7% | 0.15% | +120.0% |
| Q3 2020 | $302,000 | – | 60,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |